Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Assets Average (2016 - 2025)

Historic Assets Average for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to $545.0 million.

  • Vanda Pharmaceuticals' Assets Average fell 1623.21% to $545.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $545.0 million, marking a year-over-year decrease of 1623.21%. This contributed to the annual value of $572.6 million for FY2025, which is 1222.5% down from last year.
  • As of Q4 2025, Vanda Pharmaceuticals' Assets Average stood at $545.0 million, which was down 1623.21% from $612.9 million recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Assets Average peaked at $652.0 million during Q2 2024, and registered a low of $538.3 million during Q1 2021.
  • Its 5-year average for Assets Average is $615.2 million, with a median of $628.2 million in 2022.
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Assets Average skyrocketed by 1221.24% in 2021, and later plummeted by 1623.21% in 2025.
  • Vanda Pharmaceuticals' Assets Average (Quarter) stood at $586.8 million in 2021, then rose by 7.03% to $628.0 million in 2022, then increased by 2.71% to $645.0 million in 2023, then grew by 0.87% to $650.7 million in 2024, then decreased by 16.23% to $545.0 million in 2025.
  • Its Assets Average stands at $545.0 million for Q4 2025, versus $612.9 million for Q3 2025 and $628.3 million for Q2 2025.